Medical Professionals > Research > Clinical Trials
Clinical Trials
ECOG E5202
| |
| Cancer Type: Colon |
Description: A Randomized Phase III Study Comparing 5-FU Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular ?
|
Entity Approving The Trial:
Eastern Cooperative Oncology Group (ECOG) |
| Phase: III |
| Site-Wide Accrual Goal: 3,610 |
| |
| No related files found. |
| |
| No related links found. |
